Department of Cardiovascular Engineering, Institute of Applied Medical Engineering, Helmholtz Institute, RWTH Aachen University and University Hospital, Aachen, Germany.
Department of Radiology, Keio University School of Medicine, Tokyo, Japan.
Cardiovasc Intervent Radiol. 2022 Jan;45(1):112-120. doi: 10.1007/s00270-021-02987-y. Epub 2021 Nov 18.
The presented in-vitro study provides a comparison of various catheters for mechanical treatment of large-burden pulmonary embolism (PE) under standardized conditions, using a new test rig. Dedicated aspiration catheters (JETi®, Penumbra Indigo®, Aspirex®) were compared with standard catheters (Pigtail, Multi-Purpose, Balloon Catheter) applied for embolus fragmentation.
Emboli prepared from porcine blood were washed into the test rig which consists of anatomical models of the pulmonary artery (PA) and of the right heart in combination with a pulsatile drive system. For all catheters, the duration of the recanalization procedure and the weight percentage (wt%) of the remaining, removed and washed-down clot fractions were evaluated. For aspiration catheters, the aspirated volume was measured.
All catheters achieved full or partial recanalization. The aspiration catheters showed a significantly (p < 0.05) lower procedure time (3:15 min ± 4:26 min) than the standard fragmentation catheters (7:19 min ± 4:40 min). The amount of thrombus removed by aspiration was significantly (p < 0.001) higher than that by fragmentation, averaging 86.1 wt% ± 15.6 wt% and 31.7 wt% ± 3.8 wt%, respectively. Nonetheless, most of the residue was fragmented into pieces of ≥ 1 mm and washed down. Only in 2 of 36 tests, a residual thrombus of 11.9 wt% ± 5.1 wt% remained in the central PA.
Comparison under standardized in-vitro patho-physiological conditions showed that embolus fragmentation with standard catheters is clearly inferior to aspiration with dedicated catheters in the treatment of large-burden PE, but can still achieve considerable success.
No level of evidence, experimental study.
本体外研究使用新的测试装置,在标准化条件下比较了各种导管在机械治疗大负荷肺栓塞(PE)中的应用,其中专门的抽吸导管(JETi®、Penumbra Indigo®、Aspirex®)与标准导管(猪尾、多用途、球囊导管)用于栓子碎裂进行了比较。
从猪血中制备的栓子被冲洗到测试装置中,该装置由肺动脉(PA)和右心的解剖模型与脉动驱动系统相结合组成。对于所有导管,评估了再通程序的持续时间以及剩余、取出和冲洗下来的血栓碎片的重量百分比(wt%)。对于抽吸导管,测量了抽吸的体积。
所有导管均实现了完全或部分再通。抽吸导管的手术时间明显(p < 0.05)短于标准碎裂导管(3:15 min±4:26 min vs. 7:19 min±4:40 min)。抽吸去除的血栓量明显(p < 0.001)高于碎裂去除的量,平均分别为 86.1 wt%±15.6 wt%和 31.7 wt%±3.8 wt%。尽管如此,大部分残留物还是碎裂成 ≥ 1 mm 的碎片并被冲洗下来。仅在 36 次测试中的 2 次中,中心 PA 中仍残留 11.9 wt%±5.1 wt%的残余血栓。
在标准化的体外病理生理条件下进行比较表明,在治疗大负荷 PE 时,与标准导管的栓子碎裂相比,专用导管的抽吸明显更优,但仍能取得相当大的成功。
无证据等级,实验研究。